Expression of Na⁺–K⁺-2Cl⁻cotransporter isoform 1 (NKCC1) predicts poor prognosis in lung adenocarcinoma and<i>EGFR</i>-mutated adenocarcinoma patients

Abstract

NKCC1 high expression predicted a bad clinical outcome for lung adenocarcinoma patients andEGFR-mutated subgroup. Therefore, NKCC1 may play a role in lung adenocarcinoma and novel therapeutic tactics could be developed by targeting NKCC1 protein.